Role of Acetaldehyde in the Development of Oral Cancer

Role of Acetaldehyde in the Development of Oral Cancer
Experimental: Group I (alcohol consumption)

Participants who consume alcohol receive a standard drink or an alcohol dose that will result in a 0.03% BAC PO on study. Participants also undergo collection of saliva and breathalyzer testing throughout the trial.

Drug: Alcohol

Alcohol dose given orally that will result in a 0.03% blood alcohol concentration (BAC).

Procedure: Biospecimen Collection

Undergo saliva, mouthwash, and cheek brush collection

Procedure: Breath Test

Undergo breathalyzer testing

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 4, 2023Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments